Humbled to share my (very first) primary authored paper: Top 10 Tips for #hpm about #survonc Deeply grateful for my writing mentor @GreggWeltyMD senior author @DrN_CancerPCP wisdom of @DrNicolasHart and colleagues, mentees and friends @doc_martin19 with editorial insight of

Getting a head start on your 2026 calendar? Don't miss out on our meetings—the ultimate Place to Be to connect with peers, discover groundbreaking cancer research, and gain clinical insights. Where will we see you this year? Let us know in the comments.

We were in Mumbai, India this month for the International Palliative Care Course (IPCC), held in partnership with @TataMemorial. Participants and esteemed faculty collaborated on advancing strategies to develop and sustain PC services. Thank you, Tata Memorial! #ASCOGlobalImpact

@PalliativeMed_j Qualitative study from the Palliative Sedation Project explores the experiences of relatives and health care professionals with palliative sedation https://t.co/KT8Lxre1AN Michaël van der Elst, @SheilaPayne1 et al

Voting in the ASCO Election is open now until December 8! Meet the candidates for the Nominating Committee – Undesignated Member seat. Learn more about each candidate and make your voice heard: https://t.co/n6On5cxsd5

"Beyond respectful language, which is the minimum requirement… [this study] reinforces the broader message about maintaining respect for patients as individuals & ensuring that this is reflected in our words & deeds."   https://t.co/qxQdzTorMh @JCOOP_ASCO @ASCO @EthicsdoctorP

🟠Zanidatamab in HER2-Positive Metastatic Biliary Tract Cancer Final Results of HERIZON-BTC-01 @JAMAOnc ➡️Median follow-up: 33.4 mo ✅ORR: 41.3% ✅mOS: 15.5 mo ✅In IHC 3+ : 51.6% and 18.1 mo ❗️modest activity in IHC 2+/amplified tumors 👉 https://t.co/kuEhK9HbZn #cancer

Stellar talk by @WilliamDale_MD ! A masterclass on redefining over- and undertreatment in older adults with cancer. Important insights on moving beyond guideline-driven care toward ethical, patient-centered decision-making. Truly thought-provoking & inspiring @SIOGorg #SIOG2025

Happy #bowtie friday Remember the bigger the ureteral stone the less likely it is to pass. 5 mm stone is about 50/50 Proximal stones have further to go than a distal stone so its less likely to pass and will likely take longer

#LOS2025 @OSSOncology

A very special #BowTieFriday coming to you live from #NOLA for #LOS25. It's my joy to share my ❤️ for #pallonc for @LAOncSociety and @ACCCBuzz. Let me know your #NewOrleans recommendations below! @DrPWave @asaguirremd @mangarone23 @JMMCondor @BobMackey1 @AkSedai606 @sdbeck

🔵Preoperative PAXG vs mFOLFIRINOX for R or BR pancreatic cancer Full publ. of CASSANDRA trial @TheLancetOncol ➡️PAXG: cisplatin, nab-paclitaxel, capecitabine, and gemcitabine ➡️Design👇 ✅EFS: 16 vs 10.2 mo HR: 0.63 [0.47–0.84]; p=0.0018 ✅G3-4 AE: 66% vs 61% ⏰OS is

Excellent @PallOncCo presentation by @TamrynGray ! #CARE act important step that acknowledges and prepares caregivers @realbowtiedoc @crisbergerot @Chaosdyna @coffeemommy @IshwariaMD @GretchenMcnally

@PallOncCoP @TamrynGray @vyasabhinav2 @DarcyBurbage @Chaosdyna @jillfeldman4 @FionnualaCrowle @T4Cancer @coffeemommy @IshwariaMD @mondhiry Dr @TamrynGray summarizes the 🗻 of #challenges facing #caregivers who are supporting #HSCT patients and seeing the different (often limited) resources to help these patients. @vyasabhinav2 @DarcyBurbage @Chaosdyna @jillfeldman4 @FionnualaCrowle @T4Cancer @coffeemommy

@PallOncCoP @TamrynGray @vyasabhinav2 @DarcyBurbage @Chaosdyna @jillfeldman4 @FionnualaCrowle @T4Cancer @coffeemommy Dr @TamrynGray describes how important #caregiver support is through the spectrum of #HSCT process. #pallonc #supponc #palliheme @PallOncCoP @vyasabhinav2 @DarcyBurbage @Chaosdyna @jillfeldman4 @FionnualaCrowle @T4Cancer @coffeemommy @IshwariaMD @mondhiry

@PallOncCoP @TamrynGray @vyasabhinav2 @DarcyBurbage @Chaosdyna @jillfeldman4 @FionnualaCrowle @T4Cancer @coffeemommy #CARE act is in a majority of #US states but empows to #identify caregivers, #record in the #EHR and #notify caregivers when patient is approaching discharge.

Starting now our @PallOncCoP discussion surrounding #PsychoSocial needs for #caregivers from the dynamic Dr @TamrynGray #pallonc #supponc @vyasabhinav2 @DarcyBurbage @Chaosdyna @jillfeldman4 @FionnualaCrowle @T4Cancer @coffeemommy

Improving equitable access to comprehensive care for people with advanced breast cancer: a global expert review and call-to-action for 2025–2035 (Goal 9) https://t.co/sr2seyEHui Advanced #BreastCancer (ABC) remains treatable but incurable, and despite major therapeutic

Nice review & great work by @utswcancer team suggesting tumor macrovascular invasion = independent predictor of death. Many potential therapeutic implications: -vessel invasion as RT target -local control of peri-vascular dz as relevant endpt https://t.co/rktaWyWyS7 @OncoAlert

☢️RT for the gastric cancer ASTRO guideline 📌Preop and postop RT/CRT recommendations are based on "strenght of recom: conditional" , "quality of evidende: low-moderate" 👉 https://t.co/RtYs1JT6Sp #cancer #gastric #oncology #MedX @OncoAlert

“Simplicity is the ultimate sophistication.” Love that @EthanBasch1 seminal PROs work was published as a JAMA research letter. A reminder that impactful oncology research doesn’t always require pages of text—just a sharp, well-delivered message